ӢQ:(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronicacidӢͬx~:MLN2238;IxazoMib;(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronicacid;IXAZOMIB
؛̖ | Ҏ(gu) | (sh) | r |
---|---|---|---|
Q-0103692 | 100mg |
1
|
ԃr |
Q-0103692 | 250mg |
1
|
ԃr |
Q-0103692 | 500mg |
1
|
ԃr |
Q-0103692 | 1g |
1
|
ԃr |
Q-0103692 | 5g |
1
|
ԃr |

ɳQ
ɳ
Ӣ [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
Ąe B-[(1R)-1-[[2-[(2,5-ȱ)]]]-3-]
ܶ 1.3±0.1 g/cm3
ʽ C14H19BCl2N2O4
361.029
| 360.081482
PSA 105.64000
LogP 2.82
1.546
PaƷ
(4--9-)
c
(+)-Biotin-PEG2-amine
(R,R)-DACH- Trost w
LDK378 Dihydrochloride
Velpatasvir intermediate
Sfgw
ƫX
һ
;
aأ
SңpgӹٷƼ˾

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|ָˣ | 95%+ |
ܽl | ЙC܄/ˮ |
CAS̖ | N/A |
N/A | |
l | -20ܹⱣ |
rg | 1 |
\ݔl | Ҝ2 |
aSң | pgӹٷƼ˾ |
-
pgӹٷƼ˾ṩ Danoprevir;ITMN-191; R7227; RO5190591; RG7227CAS850876-88-9 ^N/A N/A Hʹã
-
pgӹٷƼ˾ṩ DalfopristinCAS112362-50-2 ^N/A N/A Hʹ
-
ӢQ:(3R,4R)-3-AMino-1-hydroxy-4-Methyl-2-pyrrolidinoneAcetateӢͬx~:(3R,4R)-3-AMino-1-hydroxy-4-Methyl-2-pyrrolidinoneAcetateCAS̖:1072933-71-1
-
ӢQ:DibutylphosphateӢͬx~:di-n-butylhydrogenphosphate;dp4(couplingagent);hdbp;phosphatededibutyle;di-n-butylphosphoricacid